383 related articles for article (PubMed ID: 28045028)
1. Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype.
Xue N; Zhou Q; Ji M; Jin J; Lai F; Chen J; Zhang M; Jia J; Yang H; Zhang J; Li W; Jiang J; Chen X
Sci Rep; 2017 Jan; 7():39011. PubMed ID: 28045028
[TBL] [Abstract][Full Text] [Related]
2. Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization.
Li S; Li L; Chen J; Fan Y; Wang C; Du Y; Guo C; Chen F; Li W
Ann Transl Med; 2021 Nov; 9(22):1644. PubMed ID: 34988153
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
[TBL] [Abstract][Full Text] [Related]
4. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
[TBL] [Abstract][Full Text] [Related]
5. Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling.
Chiang CF; Chao TT; Su YF; Hsu CC; Chien CY; Chiu KC; Shiah SG; Lee CH; Liu SY; Shieh YS
Oncotarget; 2017 Mar; 8(13):20706-20718. PubMed ID: 28157701
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
7. F1 fraction isolated from Mesobuthus eupeus scorpion venom induces macrophage polarization toward M1 phenotype and exerts anti-tumoral effects on the CT26 tumor cell line.
Sadeghi M; Amari A; Asadirad A; Nemati M; Khodadadi A
Int Immunopharmacol; 2024 May; 132():111960. PubMed ID: 38554440
[TBL] [Abstract][Full Text] [Related]
8. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma.
Ye J; Yang Y; Jin J; Ji M; Gao Y; Feng Y; Wang H; Chen X; Liu Y
Bioact Mater; 2020 Sep; 5(3):694-708. PubMed ID: 32478203
[TBL] [Abstract][Full Text] [Related]
10. Etomidate inhibits tumor growth of glioblastoma by regulating M1 macrophage polarization.
Gao C; Nie Y
Metab Brain Dis; 2024 Apr; 39(4):569-576. PubMed ID: 38300392
[TBL] [Abstract][Full Text] [Related]
11. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization.
Domínguez-Soto A; de las Casas-Engel M; Bragado R; Medina-Echeverz J; Aragoneses-Fenoll L; Martín-Gayo E; van Rooijen N; Berraondo P; Toribio ML; Moro MA; Cuartero I; Castrillo A; Sancho D; Sánchez-Torres C; Bruhns P; Sánchez-Ramón S; Corbí AL
J Immunol; 2014 Nov; 193(10):5181-9. PubMed ID: 25326025
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
Castro BA; Flanigan P; Jahangiri A; Hoffman D; Chen W; Kuang R; De Lay M; Yagnik G; Wagner JR; Mascharak S; Sidorov M; Shrivastav S; Kohanbash G; Okada H; Aghi MK
Oncogene; 2017 Jun; 36(26):3749-3759. PubMed ID: 28218903
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin-WA polarizes E. coli K88-induced M1 macrophage to M2-like macrophage in RAW264.7 cells.
Chen S; Lu Z; Wang F; Wang Y
Int Immunopharmacol; 2018 Jan; 54():52-59. PubMed ID: 29101873
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide-releasing molecule, CORM-3, modulates alveolar macrophage M1/M2 phenotype in vitro.
Yamamoto-Oka H; Mizuguchi S; Toda M; Minamiyama Y; Takemura S; Shibata T; Cepinskas G; Nishiyama N
Inflammopharmacology; 2018 Apr; 26(2):435-445. PubMed ID: 28674739
[TBL] [Abstract][Full Text] [Related]
17. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation.
Oishi S; Takano R; Tamura S; Tani S; Iwaizumi M; Hamaya Y; Takagaki K; Nagata T; Seto S; Horii T; Osawa S; Furuta T; Miyajima H; Sugimoto K
Immunology; 2016 Nov; 149(3):320-328. PubMed ID: 27421990
[TBL] [Abstract][Full Text] [Related]
18. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization.
Li L; Zhang HY; Zhong XQ; Lu Y; Wei J; Li L; Chen H; Lu C; Han L
Life Sci; 2020 Feb; 243():117231. PubMed ID: 31887296
[TBL] [Abstract][Full Text] [Related]
19. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
Wei J; Besner GE
J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
[TBL] [Abstract][Full Text] [Related]
20. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation.
Li J; Cai H; Sun H; Qu J; Zhao B; Hu X; Li W; Qian Z; Yu X; Kang F; Wang W; Zou Z; Gu B; Xu K
J Ethnopharmacol; 2020 Oct; 260():112969. PubMed ID: 32422358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
